Ramot At Tel Aviv University Ltd. Patent applications |
Patent application number | Title | Published |
20160130303 | GLYCOGEN SYNTHASE KINASE-3 INHIBITORS - Novel peptide inhibitors of GSK-3, compositions containing same and uses thereof are disclosed. The novel peptide inhibitors are substrate-competitive inhibitors and have an amino acid sequence designed so as to bind to a defined binding site subunit in GSK-3. Also disclosed are GSK-3 substrate competitive inhibitors which bind to the defined binding site subunit in the enzyme. Also disclosed are mutants of GSK-3 and uses thereof for identifying a putative GSK-3 substrate competitive inhibitor. | 05-12-2016 |
20160122715 | GENERATION OF CYTOTOXIC TUMOR SPECIFIC CELL LINES AND USES THEREOF - An in-vitro method of activating T cells is disclosed. The method comprises incubating T cells with pathogenic cells in the presence of a multimeric peptide comprising at least two peptide monomers linked to one another, each of the at least two peptide monomers comprising at least 6 consecutive amino acids from the amino acid sequence as set forth in SEQ ID NO: 1, wherein the at least two peptide monomers are each no longer than 30 amino acids, wherein the multimeric peptide is capable of reducing binding of PLIF to human leukocytes under conditions which allow expansion of the T cells. | 05-05-2016 |
20160120911 | TRANSPLANTATION OF CELLS INTO THE NASAL CAVITY AND THE SUBARACHNOID CRANIAL SPACE - A method of transplanting cells into a subject is disclosed. The method comprises transplanting the cells into the paranasal sinus of the subject or the subarachnoid cavity situated between the frontal bone of skull and the olfactory bulb of the subject. Devices for paranasal sinus transplantation and subarachnoid cavity transplantation are also disclosed. | 05-05-2016 |
20160115196 | SELF-ASSEMBLED MICRO-AND NANOSTRUCTURES - The present invention discloses self-assembled bioadhesive anti-microbial, anti-fouling and/or anti-oxidant micro- and nano-structures comprising a plurality of amino acids or peptides, wherein each amino acid is an aromatic amino acid comprising a catecholic moiety, and/or each peptide comprises at least one aromatic amino acid comprising a catecholic moiety. Further disclosed are methods and kits for preparing these micro- and nano-structures. Further disclosed are uses of these micro- and nano-structures in pharmaceutical, cosmetic and medical devices applications. | 04-28-2016 |
20160109539 | MAGNETIC RESONANCE MAPS FOR ANALYZING TISSUE - Apparatus for operating MRI is disclosed. The apparatus comprises: a control for operating an MRI scanner to carry out an MRI scan; an input for receiving first and second MRI scans respectively at the beginning and end of a predetermined time interval post contrast administration; a subtraction map former for forming a subtraction map from the first and the second MRI scans by analyzing the scans to distinguish between a population in which contrast clearance from the tissue is slower than contrast accumulation, and a population in which clearance is faster than accumulation; and an output to provide an indication of distribution of the populations. The control is configured to carry out the first scan at least five minutes and no more than twenty minutes post contrast administration and to carry out the second scan such that the predetermined time period is at least twenty minutes. | 04-21-2016 |
20160108434 | PHOTOCATALYTIC HYDROGEN PRODUCTION AND POLYPEPTIDES CAPABLE OF SAME - An isolated polypeptide comprising a hydrogen generating enzyme attached to a heterologous ferredoxin is disclosed, as well as polynucleotides encoding same, nucleic acid constructs capable of expressing same and cells expressing same. A method for generating hydrogen using the isolated polypeptide is also disclosed. | 04-21-2016 |
20160082161 | DRUG-ELUTING MEDICAL DEVICES - Composite structures composed of a device as a core structure, being a medical device or article, and a porous polymeric coat and designed capable of encapsulating bioactive agents while retaining the activity of these agents are disclosed. Further disclosed are processes of preparing such composite structures. | 03-24-2016 |
20160043732 | LINEARIZED OPTICAL DIGITAL-TO-ANALOG MODULATOR - A modulator device for converting digital data into modulation of an optical signal includes an electronic input for receiving an input data word of N bits and an electrically controllable modulator for modulating the intensity of an optical signal, the modulator including M actuating electrodes where M≧N. An electrode actuating device, most preferably a digital-to-digital converter, operates actuating electrodes so that at least one electrode is actuated as a function of values of more than one bit of the input data word. According to an alternative, or supplementary, aspect of the invention, the set of electrodes includes at least one electrode having an effective area which is not interrelated to others of the set by factors of two. In one preferred implementation, a Mach-Zehnder modulator also provides phase modulation to give QAM functionality. Another implementation employs a semiconductor laser. | 02-11-2016 |
20160029927 | METHOD AND SYSTEM FOR ANALYZING CRANIOFACIAL COMPLEX IMAGES - In a method of analysis, a target image is registered to define a plurality of keypoints arranged in sets corresponding to polygons or linear segments in the target image. A database of registered and annotated images is accessed and a polygon-wise comparison between the target image and each database image is employed. The comparison is used for projecting annotated locations from the database images into the target image. | 02-04-2016 |
20160027162 | METHOD AND SYSTEM FOR PROCESSING AN IMAGE - A method of processing an image having a plurality of picture-elements is disclosed. The method comprises: preprocessing the image to selectively enhance contrast of some picture-elements of the image, and employing a companding procedure for the preprocessed image, thereby providing a processed image. The contrast enhancement optionally and preferably features a mapping function having a plateau region for diminishing image data with intensity levels below an intensity threshold, thereby providing a preprocessed image. | 01-28-2016 |
20160004139 | TUNABLE NONLINEAR BEAM SHAPING BY A NON-COLLINEAR INTERACTION - A method and system for beam shaping employing a non-collinear quasi phase-matched interaction in a crystal whose nonlinear coefficient was encoded by a computer generated hologram is provided herein. The same axis is used for both satisfying the phase-matching requirements and encoding the holographic information. This allows one-dimensional beam shaping using a very simple to fabricate nonlinear crystal pattern and two-dimensional beam shaping with high conversion efficiency. Both are demonstrated by converting a fundamental Gaussian beam into Hermite-Gaussian and Laguerre-Gaussian beams at the second harmonic in KTiOPO | 01-07-2016 |
20150363672 | METHOD AND SYSTEM OF CLASSIFYING MEDICAL IMAGES - A method of generating a category model for classifying medical images. The method comprises providing a plurality of medical images each categorized as one of a plurality of categorized groups, generating an index of a plurality of visual words according to a distribution of a plurality of local descriptors in each the image, modeling a category model mapping a relation between each visual word and at least one of the categorized groups according to the index, and outputting the category model for facilitating the categorization of an image based on local descriptors thereof. | 12-17-2015 |
20150335014 | JELLYFISH-DERIVED POLYMER - Embodiments of the invention relate to jellyfish polymer comprising jellyfish protein and at least one additive, wherein the jellyfish protein comprises mucin and collagen. Further embodiments relate to hydrogels, antibacterial polymers, composite polymers and methods of making the polymers. | 11-26-2015 |
20150328330 | CONJUGATES OF A POLYMER, A BISPHOSPHONATE AND AN ANTI-ANGIOGENESIS AGENT AND USES THEREOF IN THE TREATMENT AND MONITORING OF BONE RELATED DISEASES - Conjugates of polymers or copolymers having attached thereto an anti-angiogenesis agent and a bisphosphonate bone targeting agent, and processes of preparing same, are disclosed. | 11-19-2015 |
20150322110 | DIPEPTIDE ANALOGS FOR TREATING CONDITIONS ASSOCIATED WITH AMYLOID FIBRIL FORMATION - Dipeptide analogs comprising a tryptophan (Trp) moiety coupled to a beta-sheet breaker moiety derived from alpha-aminoisobutyric acid (Aib) are disclosed. The dipeptide analogs exhibit an improved performance in inhibiting amyloid fibril formation, as compared to previously described dipeptides. Compositions containing the dipetide analogs and uses thereof in treating amyloid-associated diseases and disorders are also disclosed. | 11-12-2015 |
20150320786 | COMPOUNDS SUITED AS NANOCARRIERS FOR ACTIVE AGENTS AND THEIR USE - The invention relates to a compound suited as entity carrier, having the general formula (I) | 11-12-2015 |
20150268242 | METHODS AND KITS FOR PREDICTING PROGNOSIS OF CANCER USING SOLUBLE MORTALIN IN BLOOD - Provided are methods of determining a presence or level of soluble mortalin in a body fluid of a subject, and predicting prognosis of a subject diagnosed with cancer (e.g., solid tumor) by determining the presence or level of soluble mortalin in a body fluid of the subject. Also provided are kits for determining presence and/or level of soluble mortalin in a body fluid of the subject and/or predicting prognosis of a subject diagnosed with cancer, comprising at least two distinct antibodies to mortalin directed against different epitopes of said mortalin. | 09-24-2015 |
20150256735 | METHOD AND SYSTEM FOR PROCESSING AN IMAGE FEATURING MULTIPLE SCALES - A method of processing an image is disclosed. The method comprises obtaining an image decomposed into a set of scaled images, each being characterized by a different image-scale; and calculating, for each of at least some scaled images, a relative luminance between the scaled image and another scaled image of the set, using intensities in the scaled image and intensities in the another scaled image. The method further comprises processing each scaled image using an adaptation procedure featuring an image-specific effective saturation function of the relative luminance, thereby providing a processed scaled image; combining at least some of the processed scaled images to provide a combined image; and outputting the combined image to a computer readable medium. | 09-10-2015 |
20150229165 | RECTIFYING ANTENNA DEVICE WITH NANOSTRUCTURE DIODE - A rectifying antenna device is disclosed. The device comprises a pair of electrode structures, and at least one nanostructure diode contacting at least a first electrode structure of the pair and being at least in proximity to a second electrode structure of the pair. At least one electrode structure of the pair receives AC radiation, and the nanostructure diode(s) at least partially rectifies a current generated by the AC radiation. | 08-13-2015 |
20150216998 | ENDO180-TARGETED PARTICLES FOR SELECTIVE DELIVERY OF THERAPEUTIC AND DIAGNOSTIC AGENTS - Disclosed herein are compositions comprising lipid based particles and anti-ENDO180 antibodies and to methods of using the same for targeted delivery of therapeutic agents to cancer and fibrotic cells useful for treating cell proliferative diseases or disorders including fibrosis, cancer and to attenuate tumor progression. | 08-06-2015 |
20150194982 | LINEARIZED OPTICAL DIGITAL-TO-ANALOG MODULATOR - A modulator device for converting digital date into modulation of an optical signal includes an electronic input for receiving an input data word of N bits and an electrically controllable modulator for modulating the intensity of an optical signal, the modulator including M actuating electrodes where M≧N. An electrode actuating device, most preferably a digital-to-digital converter, operates actuating electrodes so that at least one electrode is actuated as a function of values of more than one bit of the input data word. According to an alternative, or supplementary, aspect of the invention, the set of electrodes includes at least one electrode having an effective area which is not interrelated to others of the set by factors of two. In one-preferred implementation, a Mach-Zehnder modulator also provides phase modulation to give QAM functionality. Another implementation employs a semiconductor laser. | 07-09-2015 |
20150189881 | ORNIDAZOLE AND RELATED COMPOUNDS FOR USE AS HERBICIDES - The present invention relates to the use of Ornidazole and related compounds as herbicides active on a wide range of photoautotrophic organisms. The compounds of the present invention show effective herbicidal activity while being non-hazardous to the environment and to human health. | 07-09-2015 |
20150185218 | METHODS AND SYSTEM FOR DETECTING MELANOMA - A method of determining tyrosinase activity of a cell is disclosed. The method comprises:
| 07-02-2015 |
20150075250 | Force Sensor Device - A force sensor device has at least three arcs distributed around a central axis. The arcs have integrated sensing elements that measure strain applied on the arc resulting from a force applied on the central axis. | 03-19-2015 |
20140378635 | Salenol Catalyst - Catalysts comprising salenol ligands are disclosed herein. Also, catalyst systems comprising the catalyst and an activator; methods to prepare the ligands, catalysts and catalyst systems; processes to polymerize olefins using the catalysts and/or catalyst systems; and the olefin polymers prepared according to the processes. | 12-25-2014 |
20140378634 | Thio-Salalen Catalyst - Catalysts comprising thio-salalen ligands. Also, catalyst systems comprising the catalyst and an activator; methods to prepare the ligands, catalysts and catalyst systems; processes to polymerize olefins using the catalysts and/or catalyst systems; and the olefin polymers prepared according to the processes. | 12-25-2014 |
20140343435 | METHODS AND DEVICES SUITABLE FOR IMAGING BLOOD-CONTAINING TISSUE - Disclosed are methods and devices useful for imaging blood-containing tissue, for example for angiography, especially retinal angiography, whereby an image is generated by dividing pixels of an image acquired at some wavelength range by corresponding pixels of an image acquired at a different wavelength range. In some embodiments, a first wavelength range includes predominantly light having wavelengths between about 400 nm and about 620 nm and a second wavelength range includes predominantly light having wavelengths between about 620 nm and about 800 nm. | 11-20-2014 |
20140304278 | DYNAMIC MAPS FOR EXPLORING AND BROWSING OF IMAGES - A method of mapping a collection of images, or other higher dimensional items including text documents, and three-and-higher dimensional objects, onto a navigable grid for browsing via a user interface comprises obtaining for each of the images a list of nearest neighbor images and similarity scores for each nearest neighbor; placing a first image on a cell within a grid; from a respective list of nearest neighbors of said first image, finding images that maximize a compatibility score with images already placed on the grid and placing resulting images on neighboring cells; and continuing to place further images on the grid until all cells visible to a user are filled with images. As the user pans or zooms the grid, more cells move into the visible area of the screen and are filled with images in the same way. | 10-09-2014 |
20140275454 | Diphenylamine salan catalyst - Catalysts comprising Salan ligands with bridged or unbridged diphenyl amine moieties. Also, catalyst systems comprising the catalyst and an activator; methods to prepare the ligands, catalysts and catalyst systems; processes to polymerize olefins using the catalysts and/or catalyst systems; and the olefin polymers prepared according to the processes. | 09-18-2014 |
20140271618 | ANTIBODIES TO CARCINOEMBRYONIC ANTIGEN-RELATED CELL ADHESION MOLECULE (CEACAM) - The present invention provides antibodies, as well as molecules having at least the antigen-binding portion of an antibody, recognizing a specific epitope of the protein CEACAM1 and optionally binds also other subtypes of the CEACAM protein family. Disclosed antibodies and antibody fragments are characterized by specific CDR sequences. Methods of production and use in therapy and diagnosis, of such antibodies and antibody fragments are also provided. | 09-18-2014 |
20140255972 | METHODS OF MONITORING AND ANALYZING METABOLIC ACTIVITY PROFILES DIAGNOSTIC AND THERAPEUTIC USES OF SAME - A method of measuring a metabolic activity (MA) of a cell is provided. The method comprising independently measuring in an extracellular environment of the cell, time-dependent acidification profiles due to secretion of: | 09-11-2014 |
20140249396 | IL-1 RECEPTOR ANTAGONIST-COATED ELECTRODE AND USES THEREOF - The present invention provides an electrode designed for implantation into the central nervous system (CNS) of a mammal, wherein said electrode is substantially coated with interleukin-1 receptor antagonist (IL-1ra) or a coating composition comprising it, and the IL-1ra actively inhibits scarring on or around the surface of the electrode when implanted into the CNS. The electrode of the invention may be used for brain recording and/or stimulation, and can thus be used for treatment of a brain dysfunction, a brain disease or disorder, or a brain injury, as well as for brain computer interface, brain machine interface, or electrotherapy. | 09-04-2014 |
20140213627 | NAPHTHOQUINONE DERIVATIVES USEFUL FOR PREVENTION OF AMYLOID DEPOSITS AND TREATMENT OF DISEASES INVOLVING AMYLOIDOGENESIS - The present invention provides pharmaceutical compositions comprising substituted 1,4 naphthoquinones that are effective in preventing oligomerization of beta amyloid and subsequent pathologies associated with amyloid fibrils. These compositions are useful for the treatment of disease involving amyloidogenesis including neurodegenerative diseases such as Alzheimer's Disease or senile dementia. Particularly effective compositions comprise 1,4 naphthoquinones substituted with an amino acid residue selected from a heterocyclic or aromatic amino acid. | 07-31-2014 |
20140212357 | CONJUGATE OF A POLYMER, AN ANTI-ANGIOGENESIS AGENT AND A TARGETING MOIETY, AND USES THEREOF IN THE TREATMENT OF BONE RELATED ANGIOGENESIS CONDITIONS - Conjugates of hydroxypropyl methacrylamide (HPMA)-derived copolymers having attached thereto TNP-470 and a high load (e.g., higher than 3 mol %) of alendronate (ALN), and processes of preparing same are disclosed. | 07-31-2014 |
20140208848 | COMPLIANT STRUCTURES WITH TIME-VARYING MOMENT OF INERTIA - A rotation sensor system is presented. The system comprises a rotating frame configured to be mounted on a gimbal and adapted for controllable rocking motion about a predetermined axis of said frame, and a proof mass assembly mounted on said rotating frame. The proof mass assembly comprises one or more proof mass elements each mounted for controllable movement with respect to the predetermined axis along a certain path, a distance of each proof mass element from said axis corresponding to a direction of the rocking motion of said frame, thereby affecting a moment of inertia of said rotating frame. | 07-31-2014 |
20140184224 | MAGNETIC RESONANCE METHOD FOR ANALYZING PORE SIZE DISTRIBUTION - A method of magnetic resonance analysis of a porous structure is disclosed. The method comprises: obtaining a recorded magnetic resonance signal as a function of both a magnetic resonance wavevector and a magnetic resonance angle, in response to a series of magnetic resonance experiments, each featuring a plurality of pairs of bipolar gradient pulse subsequences being characterized by a respective magnetic resonance wavevector and a respective magnetic resonance angle, where the respective magnetic resonance angle is an angle between gradient directions of the bipolar gradient pulse subsequences. The method further comprises performing an at least three-dimensional analysis of the magnetic resonance signal, so as to extract a pore size distribution from the structure; and issuing a report regarding the analysis. | 07-03-2014 |
20140177328 | Multi-Bit Magnetic Memory Cell | 06-26-2014 |
20140175171 | SYSTEM AND A METHOD FOR NANO IMPRINTING - A method for creating a highly accurate nanostructure is provided, the method includes: (i) creating a highly accurate nanostructure prototype, wherein the highly accurate nanostructure prototype, when illuminated with a predefined illumination, provides a unique optical pattern; (ii) creating at least one highly accurate nanostructure mold from the highly accurate nanostructure prototype, wherein each highly accurate nanostructure mold enables a creation of a highly accurate nanostructure that is substantially similar to the highly accurate nano structure prototype and which, when illuminated with the predefined illumination, provides the unique optical pattern; and (iii) molding the highly accurate nano structure using the highly accurate nano structure mold, wherein the highly accurate nanostructure, when illuminated with the predefined illumination, provides the unique optical pattern. | 06-26-2014 |
20140171494 | USE OF INTEGRASE FOR TARGETED GENE EXPRESSION - There are provided methods and compositions for activating the expression of an exogenous gene by an exogenous integrase specifically in cells in which the exogenous integrase is expressed. The invention further relates to uses of the compositions in treatment of various conditions and disorders, as exemplified by selectively activating expression of a toxin only in target cell populations. | 06-19-2014 |
20140165724 | BISTABLE FORCE AND/OR ACCELERATION SENSOR - A technique is provided for determining a force/acceleration acting on a proof mass of a bistable device. According to an aspect of the invention, the location of a boundary of one of the stable configurations of the device is monitored. The monitored location is compared to a predetermined location of the same boundary, said predetermined location corresponding to a condition in which the force/acceleration is absent, to detect a deviation of said location. The deviation is indicative of the force/acceleration and can be used to determine the force/acceleration. According to another aspect of the invention, the resonance frequency of the proof mass' oscillation in one of the stable regions is monitored, and compared to a predetermined resonance frequency the proof mass' oscillation in the same region corresponding to a condition in which the force/acceleration is absent, to determine a deviation of the resonance frequency due to the presence of force/acceleration. The deviation in the resonance frequency can be used to determine the force/acceleration. | 06-19-2014 |
20140162884 | HIGH TEMPERATURE SUPERCONDUCTIVE FILMS AND METHODS OF MAKING THEM - Described is a superconductive layered structure and an article including this superconductive layered structure on a substrate structure. The superconductive layered structure comprises a stack including at least one bi-layered assembly formed by first and second layers of similar superconducting material compositions, the second layer being superconductive at predetermined temperature condition, the first layer being a substantially thin layer and having a c lattice parameter selected in accordance with those of the substrate structure and the second layer, such that said first layer is non-superconductive at said predetermined temperature condition thereby allowing the second superconductive layer to be desirably thick to provide high critical current density of the superconductive layer. | 06-12-2014 |
20140161896 | PARTICLES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES - A composition of matter comprising non-cellular particles, which comprise a lysosomal enzyme and/or a small molecule which increases an amount and/or activity of a lysosomal enzyme. | 06-12-2014 |
20140154222 | ISOLATED CELLS AND POPULATIONS COMPRISING SAME FOR THE TREATMENT OF CNS DISEASES - An isolated human cell and populations thereof is provided comprising at least one astrocytic phenotype and at least one mesenchymal stem cell phenotype, wherein the mesenchymal stem cell phenotype is not an astrocytic phenotype. | 06-05-2014 |
20140140968 | MESENCHYMAL STEM CELLS FOR THE TREATMENT OF CNS DISEASES - An isolated human cell is disclosed comprising at least one mesenchymal stem cell phenotype and secreting brain-derived neurotrophic factor (BDNF), wherein a basal secretion of the BDNF is at least five times greater than a basal secretion of the BDNF in a mesenchymal stem cell. Methods of generating same and uses of same are also disclosed. | 05-22-2014 |
20140137638 | FLEXIBLE BLADE RHEOMETER - A rheometer including a flexible blade, a unit for measuring flex of at least part of the blade, a computation unit configured for converting input of parameters from the measurement unit to output of viscosity measurement. A method for determining viscosity including rotating a flexible blade in a medium whose viscosity is being measured, measuring blade flex of at least part of the blade, converting the blade flex measurement to a viscosity measurement, and producing output of determined viscosity. Related apparatus and methods are also described. | 05-22-2014 |
20140134111 | CONJUGATES OF A POLYMER, A BISPHOSPHONATE AND AN ANTI-ANGIOGENESIS AGENT AND USES THEREOF IN THE TREATMENT AND MONITORING OF BONE RELATED DISEASES - Conjugates of polymers or copolymers having attached thereto an anti-angiogenesis agent and a bisphosphonate bone targeting agent, and processes of preparing same, are disclosed. | 05-15-2014 |
20140131447 | DEVICES AND METHODS OF READING MONOCHROMATIC PATTERNS - A method of extracting data from an identifiable monochromatic pattern. The method comprises separating a polychromatic optical signal, received from an object having identifiable monochromatic pattern, into a plurality of wavelength components, separately capturing each of the wavelength components, reconstructing a plurality of images each from a different wavelength component, detecting the identifiable monochromatic pattern in one or more of the images, and extracting data associated with or encoded by the detected identifiable monochromatic pattern. The images have different depths of field. | 05-15-2014 |
20140120554 | ANTI CEACAM1 ANTIBODIES AND METHODS OF USING SAME - A hybridoma cell which has been deposited under ATCC Accession Number PTA-9974 is disclosed. Also provided are Antibodies and methods of using same. | 05-01-2014 |
20140110967 | METHODS AND APPARATUS FOR REDUCTION OF AERODYNAMIC DRAG - A method of reducing aerodynamic drag on a moving blunt-edged body, the method comprising actively generating a flow of air at a blunt edge of a body and using the generated flow of air to control an external flow of air moving relative to an edge of a moving blunt-body. | 04-24-2014 |
20140106428 | PHOTOCATALYTIC HYDROGEN PRODUCTION IN CYANOBACTERIA - A cyanobacterial cell comprising a PSI complex which accepts electrons from at least one respiratory cytochrome is disclosed. Methods of generating same and use of same for the production of hydrogen gas are also disclosed. | 04-17-2014 |
20140090818 | HEAT EXCHANGER DEVICE - A heat exchange device is presented, the device comprises one or more channels having inlet and outlet ports configured to direct flow of a predetermined fluid to and from said one or more channels. Said one or more channels of the device comprise at least one channel having at least one orifice of a predetermined hydraulic diameter configured such that a flow of said predetermined fluid through said orifice and through said channel thereby generating a vortex ring-like fashion of the flow within the channel to provide efficient heat transfer by the fluid. | 04-03-2014 |
20140088123 | TREATMENT OF LUNG CANCER - Disclosed are methods of treating lung cancer by administering to a human in need thereof effective amounts of FTS, or various analogs thereof, or a pharmaceutically acceptable salt thereof, optionally, in combination with a chemotherapeutic agent. Chemotherapeutic agents, and combinations thereof, for use with FTS, its analogs, or its salts are also disclosed. | 03-27-2014 |
20140086880 | METHOD FOR TREATING NEURODEGENERATIVE TAUOPATHY - The present invention is directed to a filamentous bacteriophage for use in treating a neurodegenerative tauopathy or susceptibility to a neurodegenerative tauopathy and a method of using the bacteriophage for reducing the formation of fibrils of tau protein or for disaggregating pre-formed fibrils of tau protein, such as in a patient suffering from neurodegenerative tauopathy. The filamentous bacteriophage used in the present invention does not display (i) a mammalian cell internalization signal (ii) a β-amyloid antigen or an antibody to β-amyloid, or (iii) a tau protein antigen or an antibody to tau protein. | 03-27-2014 |
20140079638 | NOVEL CONJUGATES OF POLYMERS HAVING A THERAPEUTICALLY ACTIVE AGENT AND AN ANGIOGENESIS TARGETING MOIETY ATTACHED THERETO AND USES THEREOF IN THE TREATMENT OF ANGIOGENESIS RELATED DISEASES - Conjugates of a polymer having attached thereto an angiogenesis targeting moiety and a therapeutically active agent such as an anti-cancer agent or anti-angiogenesis agent, and processes of preparing same are disclosed. | 03-20-2014 |
20140056334 | ENHANCED COMMUNICATION OVER NETWORKS USING JOINT MATRIX DECOMPOSITIONS - The disclosure describes examples of systems and methods for communication networks including multiple-input multiple output MIMO channels. In these examples, based on a novel decomposition of two or more channel matrices or functions thereof, a MIMO channel may be treated as a plurality of parallel scalar additive white Gaussian noise (AWGN) channels. | 02-27-2014 |
20140044949 | METHOD OF FORMING A FIBER MADE OF PEPTIDE NANOSTRUCTURES - A method of forming a fiber made of peptide nanostructures is disclosed. The method comprises: providing peptide nanostructures in solution, and fiberizing the solution thereby forming at least one fiber of the peptide nanostructures. Also disclosed are methods of forming films and other articles using the peptide nanostructures. | 02-13-2014 |
20140039581 | LOW LEVEL LASER THERAPY FOR ALZHEIMER'S DISEASE - Methods and systems are provided for delivering visible or infrared biostimulatory energy to bone marrow to subjects having or developing Alzheimer's disease. The radiation is delivered to sites remote from the brain at a dose sufficient to cause stimulated mesenchymal stem cells to appear in the brain and degrade β-amyloid. The energy may be coherent light and can be administered transcutaneously, subcutaneously, or via an intramedullary probe. | 02-06-2014 |
20140027655 | PEPTIDE NANOSTRUCTURES AND METHODS OF GENERATING AND USING THE SAME - A tubular or spherical nanostructure composed of a plurality of peptides, wherein each of the plurality of peptides includes no more than 4 amino acids and whereas at least one of the 4 amino acids is an aromatic amino acid. | 01-30-2014 |
20140026664 | SYSTEM FOR AUTOMATIC FALL DETECTION FOR ELDERLY PEOPLE - Apparatus for detection of human falls comprises: an acceleration detector, for detecting vibration events, typically placed on a floor, a microphone, located in association with the acceleration detector for detection of corresponding sound events, and a classification unit to classify concurrent events from the microphone and the acceleration detector, thereby to determine whether a human fall is indicated. If the event appears to be a human fall, then an alarm is raised. | 01-30-2014 |
20140024710 | 5-AMINOLEVULINIC ACID DERIVATIVES, METHODS FOR THEIR PREPARATION AND USES THEREOF - The present invention provides drug conjugates comprising 5-aminolevulinic acid (ALA), an aldehyde and a carboxylic acid that may function as a histone deacetylase inhibitor (HDACI). These conjugates may serve as co-drugs which release a plurality of active species in vivo. The novel drug conjugates may be used, for the treatment or prevention of cancer in PDT-dependent and/or PDT-independent (nonPDT) treatments, as well as for cosmetic uses. In addition the present invention provides novel uses for both the novel and known compounds. According to some embodiments, the present invention provides drug conjugates (co-drugs) comprising (i) ALA, (ii) an aldehyde and (iii) a carboxylic acid that may function as a histone deacetylase inhibitor (HDACO for the treatment of anemia and/or for the induction of erythropoiesis. | 01-23-2014 |
20140012504 | QUANTITATIVE ASSESSMENT OF SOIL CONTAMINANTS, PARTICULARLY HYDROCARBONS, USING REFLECTANCE SPECTROSCOPY - Apparatus and method for efficiently assessing the results of reflectance spectroscopy on a soil sample to determine the presence of contaminants in the soil, by constructing a model based on analysis of known samples. The model may be constructed using an all possibilities approach and data mining techniques, on a range of samples, for example of different kinds of soil without pollutants and with different levels of pollutants. The Disclosure relates both to the construction of the model and to its use in the field in analyzing soil contaminants. | 01-09-2014 |
20140010763 | ACTIVATABLE FLUOROGENIC COMPOUNDS AND USES THEREOF AS NEAR INFRARED PROBES - Novel fluorogenic compounds designed such that upon a chemical event, compounds capable of emitting NIR light are generated, are disclosed. The compounds comprise two or more acceptor-containing moieties and a cleavable donor-containing moiety, being in complete pi-electrons conjugation and being such that no delocalization of pi-electrons is enabled. Also disclosed are fluorescent compounds generated upon subjecting the fluorogenic compounds to a chemical event (e.g., deprotonation). Also disclosed are uses of the fluorogenic compounds as NIR probed with a Turn-ON mechanism in monitoring presence and/or level of various analytes. | 01-09-2014 |
20130344079 | COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING PHENYLKETONURIA (PKU) - A method of diagnosing Phenylketonuria (PKU) in a subject in need thereof is disclosed. The method comprises detecting phenylalanine fibrils in a tissue of the subject, wherein a presence or level above a predetermined threshold of said phenylalanine fibrils in said tissue, is indicative of PKU in the subject. Antibodies capable of detecting phenylalanine fibrils are also disclosed as well as additional uses. | 12-26-2013 |
20130332133 | Classification of Protein Sequences and Uses of Classified Proteins - A searchable protein database is disclosed. The protein database comprises a plurality of entries, each entry having a sufficiently short predicting sequence and a protein classifier corresponding to the predicting sequence. An unclassified protein sequence can be classifiable by the database via searching therein for a motif of amino acids matching a predicting sequence of the database, thereby attributing to the unclassified protein a protein classifier. | 12-12-2013 |
20130329216 | METHODS AND KITS FOR DETECTION OF DRUGS - The present invention discloses a method for determining the presence of a drug or drug mixture in a liquid medium such as a beverage. | 12-12-2013 |
20130316331 | DETECTION OF INFECTION BY A MICROORGANISM USING SMALL RNA SEQUENCING SUBTRACTION AND ASSEMBLY - There is provided a method for the detection and identification of infection of a subject by a microorganism, wherein the method is based on the use of small RNA derived sequences and subtraction and assembly thereof. | 11-28-2013 |
20130315869 | BACTERIOPHAGES FOR REDUCING TOXICITY OF BACTERIA - A genetically modified bacteriophage is disclosed which comprises:
| 11-28-2013 |
20130310529 | METAL COMPLEXES OF SALAN-TYPE LIGANDS AND USES THEREOF AS CATALYSTS FOR POLYMERIZATION OF ALPHA-OLEFINS - Use of homogeneous catalytic systems which include as a pre-catalyst a complex of a group 4 metal and a Salan ligand in the polymerization of alpha-olefins, is disclosed. The Salan ligand is characterized by a sequential diamino-containing skeleton unit which is non-symmetric, and the pre-catalysts can also be such that are devoid of a symmetry element. The disclosed polymerization results in alpha-olefin polymers such as polypropylene which are characterized by high levels of tacticity. Also disclosed are novel Salan ligands and novel complexes thereof with group 4 metals. | 11-21-2013 |
20130310446 | MIR-21 PROMOTER DRIVEN TARGETED CANCER THERAPY - The invention provides a nucleic acid construct comprising a promoter sequence derived from microRNA-21 (miR-21) linked to a nucleic acid sequence encoding an anti-cancer agent, an example of which is a toxin. The constructs of the invention are particularly useful for treating tumors expressing miR-21. | 11-21-2013 |
20130310303 | GLYCOGEN SYNTHASE KINASE-3 INHIBITORS - Novel peptide inhibitors of GSK-3, compositions containing same and uses thereof are disclosed. The novel peptide inhibitors are substrate-competitive inhibitors and have an amino acid sequence designed so as to bind to a defined binding site subunit in GSK-3. Also disclosed are GSK-3 substrate competitive inhibitors which bind to the defined binding site subunit in the enzyme. Also disclosed are mutants of GSK-3 and uses thereof for identifying a putative GSK-3 substrate competitive inhibitor. | 11-21-2013 |
20130308682 | DISTRIBUTED AND DYNAMICAL BRILLOUIN SENSING IN OPTICAL FIBERS - A method of distributed and dynamical Brillouin sensing in optical fibers is provided herein. The method includes the following stages: deriving average characteristics of an optical fiber along its length; generating a variable frequency probe signal, such that the variable frequency is tailored to match, at specified points along the fiber, the respective average characteristics; injecting the variable frequency probe signal to a first end of the optical fiber and a periodic pulse signal to a second end of the optical fiber, wherein the injecting is synchronized such that a stimulated Brillouin scattering is carried out at each one of the specified points along the optical fiber, such that a frequency difference between the probe signal and the pump signal matches the average characteristics of the fiber; and measuring occurrences of the stimulated Brillouin scattering, to yield data indicative of strain and temperature at all points along the optical fiber. | 11-21-2013 |
20130307524 | INFERRING THE PERIODICITY OF DISCRETE SIGNALS - A method for testing a signal comprises obtaining a signal, determining whether the signal has at least one period, measuring that period and providing the measurement as output. A power spectral density estimation can be used for signals having a single period, and an autocorrelation function with slicing can be used in an iterative procedure for finding multiple periods within signals. | 11-21-2013 |
20130303441 | GLYCOGEN SYNTHASE KINASE-3 INHIBITORS - Novel peptide inhibitors of GSK-3, compositions containing same and uses thereof are disclosed. The novel peptide inhibitors are substrate-competitive inhibitors and have an amino acid sequence designed so as to bind to a defined binding site subunit in GSK-3. | 11-14-2013 |
20130299772 | HEAVILY DOPED SEMICONDUCTOR NANOPARTICLES - Herein, provided are heavily doped colloidal semiconductor nanocrystals and a process for introducing an impurity to semiconductor nanoparticles, providing control of band gap, Fermi energy and presence of charge carriers. The method is demonstrated using InAs colloidal nanocrystals, which are initially undoped, and are metal-doped (Cu, Ag, Au) by adding a metal salt solution. | 11-14-2013 |
20130259642 | METHOD AND SYSTEM OF PROVIDING FLUID FLOW FOR A ROTOR - A rotor which comprises at least one blade and at least one fluid routing device that is mechanically connected to one of the blades so that a fluid inlet thereof is placed in a lateral edge of the blade. The fluid routing device has a continuous channel with an inlet facing the opposite direction of rotation of the blades and an outlet. The continuous channel is sized and shaped to conduct fluid passing via the inlet. The fluid routing device includes a flow directing element that is mechanically connected to the outlet so as to direct the conducted fluid to adjust fluid flow in or on the mechanically connected blade. | 10-03-2013 |
20130254197 | METHOD AND SYSTEM FOR DECOMPRESSION-FREE INSPECTION OF SHARED DICTIONARY COMPRESSED TRAFFIC OVER HTTP - A system and a method for decompression-free inspection of compressed data are provided herein. The method includes the following stages: obtaining a dictionary file comprising a string of symbols, each associated with a respective index; obtaining at least one delta file associated with said dictionary file, wherein said delta file comprises a sequence of instructions that include at least one copy instruction pointing to an index within said dictionary and a length of a copy substring to be copied; scanning said dictionary using a pattern matching algorithm associated with a plurality of patterns and implemented as a Deterministic Finite Automaton (DFA), to yield DFA execution data; scanning said at least one delta file, using said pattern matching algorithm, wherein said DFA execution data is used to skip at least part of the scanning of the copy substrings for at least one of the copy instructions. | 09-26-2013 |
20130253608 | BLIND SIGHT - A sensory substitution device (SSD) for providing a person with neural signals responsive to features of an environment, the SSD comprising: at least one camera that acquires an image of the environment; and at least one corneal neural stimulator that stimulates nerve endings in the cornea of an eye of the person to generate neural signals responsive to the image that propagate to the person's brain. | 09-26-2013 |
20130252905 | PLIF MULTIMERIC PEPTIDES AND USES THEREOF - Provided is a multimeric peptide comprising at least two peptide monomers linked to one another, each of the at least two peptide monomers comprising at least 6 consecutive amino acids from the amino acid sequence as set forth in SEQ ID NO: 1, wherein the at least two peptide monomers are each no longer than 30 amino acids, wherein the multimeric peptide is capable of reducing binding of Placenta Immunomodulatory Factor (PLIF) to human leukocytes. | 09-26-2013 |
20130245606 | HYDROGEL BASED OCCLUSION SYSTEMS - A hydrogel based occlusion system, a method for occluding vessels, appendages or aneurysms, and a method for hydrogel synthesis are disclosed. The hydrogel based occlusion system includes a hydrogel having a shrunken and a swollen state and a delivery tool configured to deliver the hydrogel to a target occlusion location. The hydrogel is configured to permanently occlude the target occlusion location in the swollen state. The hydrogel may be an electro-activated hydrogel (EAH) which could be electro-activated with a delivery system to control the degree of swelling/shrinking. | 09-19-2013 |
20130244946 | COMPOSITIONS AND METHODS FOR PREVENTION AND TREATMENT OF NEURODEGENERATIVE DISEASES - Isolated peptides are provided, being less than 20 amino acids in length. The peptides comprising an amino acid sequence GVLYVGSKTREGV (SEQ ID NO: 12) AAATGLVKREE (SEQ ID NO: 13) or GVVAAAEKTKQG (SEQ ID NO: 14), mimetics and/or fragment thereof, the peptides being capable of inhibiting alpha synuclein aggregation. Pharmaceutical compositions comprising same are also provided as well as uses thereof. | 09-19-2013 |
20130244102 | ELECTROPHORETIC DEPOSITION OF THIN FILM BATTERIES - Methods for forming three-layer thin-film battery (TFB) structures by sequential electrophoretic deposition (EPD) on a single conductive substrate. The TFBs may be two-dimensional or three-dimensional. The sequential EPD includes EPD of a first battery electrode followed by EPD of a porous separator on the first electrode and by EPD of a second battery electrode on the porous separator. In some embodiments of a Li or Li-ion TFB, the separator includes a Li ion conducting solid. In some embodiments of a Li or Li-ion TFB, the separator includes an inorganic porous solid rendered ionically conductive by impregnation with a liquid or polymer. In some embodiments, the TFBs are coated and sealed with an EPDd PEEK layer. | 09-19-2013 |
20130236964 | METHODS, NUCLEIC ACID CONSTRUCTS AND CELLS FOR TREATING NEURODEGENERATIVE DISORDERS - A method of treating a neurodegenerative disorder is provided. The method is effected by administering to an individual in need thereof cells capable of exogenously regulatable neurotransmitter synthesis thereby treating the neurodegenerative disorder. | 09-12-2013 |
20130230747 | DIRECT LIQUID FUEL CELL HAVING AMMONIA BORANE, HYDRAZINE, DERIVATIVES THEREOF OR/AND MIXTURES THEREOF AS FUEL - A fuel cell system comprising an anode compartment which comprises an anode having a copper catalyst layer, a cathode configured as an air cathode and a separator interposed between said anode and said cathode, operable by an amine-derived fuel and oxygen (or air) is disclosed. Further disclosed are fuel cell systems comprising an anode compartment which comprises an anode having a copper catalyst layer, a cathode and a separator interposed between said anode and said cathode, which are operable by a mixture of two types of amine-derived compounds (e.g., ammonia borane, hydrazine and derivatives thereof). Also disclosed are methods of producing electric energy by, and electric-consuming devices containing and operable by, the disclosed fuel cell systems. | 09-05-2013 |
20130226310 | CORAL BONE GRAFT SUBSTITUTE - This invention provides a method for producing bioactive coral bone graft substitutes and to products obtained thereby. | 08-29-2013 |
20130224789 | METHODS OF MONITORING AND ANALYZING METABOLIC ACTIVITY PROFILES DIAGNOSTIC AND THERAPEUTIC USES OF SAME - A method of measuring a metabolic activity (MA) of a cell is provided. The method comprising independently measuring in an extracellular environment of the cell, time-dependent acidification profiles due to secretion of: | 08-29-2013 |
20130218145 | SYSTEM AND METHOD FOR TREATING AN EYE - The invention provides a device for delivering electromagnetic radiation to a limbal area of an eye that transforms one or more beams of electromagnetic radiation that are incident on a first side into one or more emitted beams of the electromagnetic radiation where the one or more beams are arrayed in a cylindrical array, an array of one or more beams each beam having a cross sectional shape of a circular arc or an array comprising a beam having an annular cross section. The invention also provides a system for delivering electromagnetic radiation to the limbal area of an eye that includes one or more devices of the invention and a source of electromagnetic radiation. The system may be used in the treatment of glaucoma. | 08-22-2013 |
20130217996 | METHOD AND SYSTEM FOR ANALYZING IMAGES - A method of analysis is disclosed. The method comprises: registering a target image to define a plurality of keypoints arranged in sets corresponding to polygons or linear segments in the target image; accessing a database of registered and annotated images, and employing a polygon-wise comparison between the target image and each database image; and using the comparison for projecting annotated locations from the database images into the target image. | 08-22-2013 |
20130217681 | METHOD AND COMPOSITION FOR WEIGHT-GAIN MANAGEMENT - Presented herein is a methodology for reducing weight in obese subjects and in patients receiving various medical treatments that are accompanied with weight gain. The methodology allows for management of weight gain, management of triglyceride levels and weight reduction in obese subjects. | 08-22-2013 |
20130209421 | INDUCED PLURIPOTENT STEM CELLS DERIVED FROM HUMAN PANCREATIC BETA CELLS - A method of generating pluripotent stem cells is described. The method comprises:
| 08-15-2013 |
20130203689 | CHEMICAL DERIVATIVES OF JASMONATE, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE THEREOF - The present invention relates to novel jasmonate derivatives, methods for their preparation, pharmaceutical compositions including such compounds, and methods of using these compounds and compositions, especially as chemotherapeutic agents for prevention and treatment of cancers. | 08-08-2013 |
20130202598 | ACTIVATABLE TOXIN COMPLEXES COMPRISING A CLEAVABLE INHIBITORY PEPTIDE - The present invention relates to activatable toxin complexes which include a cleavable inhibitory peptide. More specifically, the complexes comprise a cell targeting domain, a toxin catalytic domain, a specific protease cleavage site and an inhibitory peptide domain. The inhibitory peptide prevents the catalytic domain from exerting toxic effects until its release from the complex by the action of a protease, such a viral protease, at the protease cleavage site. Further provided are pharmaceutical compositions comprising the complexes and use thereof for treating infections and malignant disease. | 08-08-2013 |
20130194410 | CELL OCCUPANCY MEASUREMENT - A method for determining cell occupancy, confluency and cell migration in a cell culture, comprising receiving data related to pixel intensity in an image acquired of the cell culture, and distinguishing between cell concentrations in different locations in the cell culture by detecting variations in pixel intensity between multi pixel locations. | 08-01-2013 |
20130191579 | APPARATUS AND METHOD FOR ENHANCING FLASH ENDURANCE BY ENCODING DATA - Input bits are stored in memory cells by mapping the input bits into a larger number of transformed bits using a shaping encoding that has a downward asymptotic bias with respect to a mapping of bit patterns to cell states and programming some of the cells according to that mapping of bit patterns to cell states. The programmed cells are erased before being programmed to store any other bits. The invention sacrifices memory capacity to increase endurance. | 07-25-2013 |
20130184347 | ACID ADDITION SALT OF A NORTRIPTYLINE-GABA CONJUGATE AND A PROCESS OF PREPARING SAME - An acid addition salt of a nortriptyline-GABA conjugate, a novel crystalline form of a fumaric acid addition salt of a nortriptyline-GABA conjugate, and processes of preparing the forgoing are disclosed. Uses of the above-indicated forms of a nortriptyline-GABA conjugate in the treatment of CNS disorders, and in the treatment of pain in particular, are also disclosed. Further disclosed in a large-scale process of preparing a nortriptyline-GABA conjugate. | 07-18-2013 |
20130177533 | METHOD FOR TREATING INFLAMMATION ASSOCIATED WITH AMYLOID DEPOSITS AND BRAIN INFLAMMATION INVOLVING ACTIVATED MICROGLIA - Filamentous bacteriophage which does not display an antibody or a non-filamentous bacteriophage antigen on its surface is used to inhibit or treat brain inflammation associated with amyloid deposits and/or involving activated microglia, to inhibit the formation of amyloid deposits, and to disaggregate pre-formed amyloid deposits. | 07-11-2013 |
20130164743 | METHOD FOR DIAGNOSING AND MONITORING SCHIZOPHRENIA AND TAUOPATHIES - The present invention provides methods and kits for diagnosing or monitoring conditions such as schizophrenia and tauopathies in a patient by determining the level of ADNP1 or ADNP2 in a sample from the patient. | 06-27-2013 |
20130157149 | RECHARGEABLE ALKALI METAL-AIR BATTERY - An energy storage cell ( | 06-20-2013 |
20130150352 | CRYSTALLINE FORMS OF THE TRI-MESYLATE SALT OF PERPHENAZINE-GABA AND PROCESS OF PRODUCING THE SAME - Novel crystalline form of perphenazine 4-aminobutyrate trimesylate and a process of producing the same are disclosed. The novel crystalline form is characterized by a unique XRPD pattern and a DSC that exhibits an endothermic peak at a relatively high temperature (e.g., higher than 209° C.). Also disclosed are a process of preparing perphenazine 4-aminobutyrate trimesylate by in situ deprotection and salification, in a single-step synthesis, and a highly pure perphenazine 4-aminobutyrate trimesylate obtained thereby. Uses of any of the described perphenazine 4-aminobutyrate trimesylate are also disclosed. | 06-13-2013 |
20130148908 | METHOD AND SYSTEM FOR PROCESSING AN IMAGE FEATURING MULTIPLE SCALES - A method of processing an image is disclosed. The method comprises obtaining an image decomposed into a set of scaled images, each being characterized by a different image-scale; and calculating, for each of at least some scaled images, a relative luminance between the scaled image and another scaled image of the set, using intensities in the scaled image and intensities in the another scaled image. The method further comprises processing each scaled image using an adaptation procedure featuring an image-specific effective saturation function of the relative luminance, thereby providing a processed scaled image; combining at least some of the processed scaled images to provide a combined image; and outputting the combined image to a computer readable medium. | 06-13-2013 |
20130143960 | NOVEL SEROTONIN REUPTAKE INHIBITORS AS DRUGS HAVING PERIPHERAL-SYSTEM-RESTRICTED ACTIVITY - Serotonin reuptake inhibitor compounds which are designed to exert serotonin uptake inhibitory activity in the peripheral system while being devoid of CNS activity, and a process of preparing same are disclosed. Further disclosed are pharmaceutical compositions containing same and uses thereof in the treatment of medical conditions associated with peripheral serotonin levels and/or activity, and/or platelet aggregation. | 06-06-2013 |
20130141768 | TILTING ACTUATOR WITH CLOSE-GAP ELECTRODES - A tunable tilting device is described. The device includes a tilting element and a suspension structure that has one or more flexures coupled to the tilting element. The suspension structure has a variable bending stiffness and configured to bend due to a tilting motion of the tilting element around a pivot axis. The suspension structure is responsive to a tuning force actuating a variation of an extension stress or a compression stress of the suspension structure, and thereby can vary the bending stiffness of the suspension structure. | 06-06-2013 |
20130132791 | INTERRUPTION CRITERIA FOR BLOCK DECODING - While decoding a representation, imported from a channel, of a codeword that encodes K information bits as N>K codeword bits, by updating estimates of the codeword bits in a plurality of iterations, the iterations are interrupted upon satisfaction of an interruption criterion that is either an order-dependent interruption criterion or an interruption criterion that includes an estimate of mutual information of the codeword and a vector that is used in the decoding iterations. Either the iterations are terminated or the iterations are resumed after one or more elements of one or more vectors used in the iterations is/are modified. | 05-23-2013 |
20130131048 | NOVEL PSYCHOTROPIC AGENTS HAVING GLUTAMATE NMDA ACTIVITY - The invention provides novel compounds and pharmaceutical compositions for the treatment of psychological and/or psychiatric diseases or disorders. | 05-23-2013 |
20130129810 | IRON OXIDE NANOPARTICLES FOR USE IN TREATING NON-INFECTIOUS INFLAMMATORY DISORDERS - In accordance with the present disclosure there are provided iron oxide nanoparticles for use in the treatment of non-infectious inflammatory disorders. Also provided by the present disclosure is a method of treatment of non-infectious inflammatory disorders making use of such particles, pharmaceutical compositions and kits comprising such particles | 05-23-2013 |
20130123761 | SYSTEM AND METHOD FOR TREATING AN EYE - A system and method are presented for use in delivering electromagnetic radiation to a limbal area of an eye, for example for treatment of glaucoma. The system includes an illumination unit, a beam shaping device and a control unit. The illumination unit includes a first source of electromagnetic radiation configured and operable for producing a beam of electromagnetic radiation having first optical properties to be delivered to the limbal area of a patient's eye to interact therewith and produce a desired effect, and a second source of electromagnetic radiation configured and operable for producing a beam of electromagnetic radiation having second optical properties. The beam shaping device when accommodated in an optical path of said first and second beams defines one or more regions along a path substantially aligned with a limbus of the patient's eye. The control unit is configured and operable for operating the illumination unit in first and second illumination modes, such that in the first illumination mode the second beam propagates towards said beam shaping device and upon identifying that the second beam illuminates the limbus, the second illumination mode is activated in which the first beam is directed via said beam shaping device to pass through said one or more regions along said path to thereby interact with the limbus. | 05-16-2013 |
20130123365 | USE OF FTS AND ANALOGS TO TREAT NON-AUTOIMMUNE-ALLERGIC AND NON-ALLERGIC INFLAMMATORY CONDITIONS - Disclosed are methods of treating a mammalian subject afflicted with a non-autoimmune inflammatory condition, comprising administering to the subject a pharmaceutical composition comprising an effective amount of S-farnesylthiosalicylic acid (FTS) or a structural analog thereof, and compositions useful in the practice of the methods. | 05-16-2013 |
20130123187 | PEPTIDES FOR THE REGULATION OF NEUROTRANSMITTER SEQUESTRATION AND RELEASE - A method of selecting an agent comprising a neuroprotecting activity is disclosed. The method comprises:
| 05-16-2013 |
20130123186 | NEUROPROTECTION USING NAP-LIKE AND SAL-LIKE PEPTIDE MIMETICS - This invention relates to NAP-like and SAL-like peptide mimetics, polypeptides, or small molecules derived from them, and their use in the treatment of neuronal dysfunction, neurodegenerative disorders cognitive deficits, neuropsychiatric disorders, and autoimmune disease. | 05-16-2013 |
20130122491 | SYSTEMS AND METHODS FOR DETECTION OF CELLULAR STRESS - There are provided methods for detection and measurement of stress in a cell, the method including introducing a labeled tRNA into the cell and detecting a change in subcellular localization of the labeled tRNA in the cell, based on the signal emitted from the labeled tRNA. There are further provided methods and systems for the generation of a stress index of a living cell. There are further provided methods and systems for detection of stress in a living cell, comprising detection of changes in subcellular localization of labeled tRNA in a cell, wherein the detection is performed in real time. | 05-16-2013 |
20130116652 | CATHETER CANNULA WITH ANCHORING ELEMENTS, CATHETER INCLUDING THEREOF, AND/OR CATHETERIZATION METHOD USING - Catheter cannula, catheter, and catheterization method, for administering a fluid or/and substance to, or for draining a fluid or/and substance from, a treatment space of a body vessel, duct, or cavity. In some embodiments the cannula includes: an elongated flexible tube mountable on a needle, and having an invasive section and a non-invasive section; and at least one anchoring element protruding from, a surface of the invasive section in a manner such that an operative configuration of each anchoring element increases outer circumferential diameter of the cannula to an extent less than lumen diameter of the body vessel, duct, or cavity, at the treatment space, thereby anchoring the invasive section to inside the body vessel, duct, or cavity, at the treatment space. The catheter includes a needle and the cannula mounted thereupon. | 05-09-2013 |
20130116326 | TREATMENT OF DELAYED CUTANEOUS HYPERSENSITIVITY CONDITIONS WITH S-FARNESYLTHIOSALICYLIC ACID AND ANALOGS THEREOF - Disclosed are methods of treating a mammalian subject afflicted with a delayed cutaneous hypersensitivity condition, comprising administering to the subject a pharmaceutical composition comprising an effective amount of S-farnesylthiosalicylic acid (FTS) or a structural analog thereof, and compositions for use in the methods. | 05-09-2013 |
20130115705 | FUNCTIONALIZED NANOSTRUCTURES FOR DETECTING NITRO-CONTAINING COMPOUNDS - Devices, methods and systems for detecting nitro-containing compounds such as TNT, which utilize semiconductor nanostructures modified by a functional moiety that interacts with the nitro-containing compound, are disclosed. The functional moiety is attached to the nanostructures and is being such that upon contacting a sample that contains the nitro-containing compound, the nanostructure exhibits a detectable change in an electrical property, which is indicative of the presence and/or amount of the nitro-containing compound in the sample. Electronic noses for generating recognition patterns of various nitro-containing compounds, comprising a plurality of nanostructures modified by versatile functional moieties are also disclosed. The devices, methods and systems are suitable for detecting nitro-containing compounds in both liquid and gaseous states and for detecting a concentration of a nitro-containing compound such as TNT as low as attomolar concentrations. | 05-09-2013 |
20130115645 | FGL-2 PROTHROMBINASE AS A DIAGNOSTIC TOOL FOR MALIGNANCY - The present: invention reveals a strong correlation between FGL-2 prothrombinase activity levels and the presence of a malignant proliferative disorder in a subject. Thus, the present invention provides FGL-2 prothrombinase activity as a diagnostic tool for malignancy. | 05-09-2013 |
20130106415 | MAGNETIC RESONANCE ANALYSIS USING A PLURALITY OF PAIRS OF BIPOLAR GRADIENT PULSES | 05-02-2013 |
20130096271 | SALALEN LIGANDS AND ORGANOMETALLIC COMPLEXES - Use of homogeneous catalytic systems which include as a pre-catalyst a complex of a Group IV metal and a salalen ligand in the polymerization of alpha-olefins, is disclosed. The alpha-olefin polymers obtained are characterized by controlled levels of tacticity. Also disclosed are novel salalen ligands and novel complexes thereof with Group IV metals. | 04-18-2013 |
20130079421 | MALLEABLE HYDROGEL HYBRIDS MADE OF SELF-ASSEMBLED PEPTIDES AND BIOCOMPATIBLE POLYMERS AND USES THEREOF - Hybrid hydrogels formed of a plurality of peptides that are capable of self-assembling into a hydrogel in an aqueous solution and a biocompatible polymer that is characterized by high swelling capability, high elasticity and low mechanical strength are disclosed, with exemplary hybrid hydrogels being formed of a plurality of aromatic dipeptides and hyaluronic acid. The hybrid hydrogels are characterized by controllable mechanical and biological properties which can be adjusted by controlling the concentration ratio of the peptides and the polymer, and which average the mechanical and biological properties of the peptides and the polymer. Processes of preparing the hydrogels and uses thereof in pharmaceutical, cosmetic or cosmeceutic applications such as tissue engineering and/or regeneration are further disclosed. | 03-28-2013 |
20130078513 | THREE-DIMENSIONAL MICROBATTERY HAVING A POROUS SILICON ANODE - An electrical energy storage device ( | 03-28-2013 |
20130075703 | PEPTIDE NANOSTRUCTURES ENCAPSULATING A FOREIGN MATERIAL AND METHOD OF MANUFACTURING SAME - A composition comprising a material at least partially enclosed by a tubular, spherical or planar nanostructure composed of a plurality of peptides, wherein each of the plurality of peptides includes no more than 4 amino acids and whereas at least one of the 4 amino acids is an aromatic amino acid. | 03-28-2013 |
20130071401 | METHODS OF TREATING DIABETES AND COMPOSITIONS CAPABLE OF SAME - A composition of matter is disclosed which comprises isolated oligomers of human islet amyloid polypeptide (IAPP). Antibodies recognizing same are also disclosed. Use of the composition of matter and the antibodies are also disclosed. | 03-21-2013 |
20130070046 | METHOD AND SYSTEM FOR CORRECTING GAZE OFFSET - A method of correcting gaze offset in an image of at least one individual having eyes is disclosed. The method comprises: processing the image to extract location of at least one eye over the image, processing the image to replace imagery data associated with each location of each eye with replacement data thereby providing a corrected image, and transmitting the corrected image to a display device. The replacement data are preferably previously-recorded imagery data which respectively correspond to the same eye but a different gaze. | 03-21-2013 |
20130059910 | CONJUGATES COMPRISING A GABA- OR GLYCINE COMPOUND, PHARMACEUTICAL COMPOSITIONS AND COMBINATIONS THEREOF AS WELL AS THEIR USE IN TREATING CNS DISORDERS - A novel use of conjugates of psychotropic drugs (e.g., antidepressants or anti-epileptic drugs) and organic acids such as GABA in the treatment of pain is disclosed. A novel GABA conjugate and uses thereof is also disclosed. | 03-07-2013 |
20130053320 | TREATMENT OF ANEMIA BY ADNP AND ADNF POLYPEPTIDES - This invention relates to the use of ADNP, ADNP2, and ADNF polypeptides in the treatment of anemia and related conditions. Compositions of the ADNP, ADNP2, or ADNF polypeptides for such use are disclosed. Also provided are methods for concentrating or extracting ADNP, ADNP2, or ADNF polypeptides from dairy products and the use of dairy products in the context of treating anemia. | 02-28-2013 |
20130045933 | ALOE-EMODIN DERIVATIVES AND USE THEREOF FOR THE TREATMENT OF CANCER - The present invention relates to anthracycline derivatives that are based on an Aloe-emodin (AE) backbone attached to a glycoside (an amino sugar or amino carba-sugar). These derivatives are useful as chemotherapeutic agents. Advantageously, these derivatives are potent cytotoxic agents against a variety of anthracycline-resistant tumors. In addition, they may have reduced cardiotoxicity. As such, the novel compounds of the invention offer an advantage over currently available drugs. The present invention further relates to methods for preparing the novel Aloe-Emodin Glycoside (AEG) based derivatives, pharmaceutical compositions including such compounds, and methods of using these compounds and compositions, especially as chemotherapeutic agents for prevention and treatment of cancers. | 02-21-2013 |
20130035390 | TREATMENT OF MULTIPLE SCLEROSIS - Disclosed are methods for treating multiple sclerosis patients that entail co-administration of effective amounts of a Ras antagonist which is farnesylthiosalicylic acid or an analog thereof, and a second active agent selected from glatiramer acetate, laquinimod and combinations thereof. Therapeutic compositions and methods of making them are also disclosed. | 02-07-2013 |
20130033739 | ELECTROVARIABLE NANOPLASMONICS AND SELF-ASSEMBLING SMART MIRRORS - Systems and methods provide control of nanoparticle coverage of an interface between a first medium and a second medium through variation of an electric potential across such interface; the first medium and the second medium are immiscible media, and transparent or substantially transparent to visible light. The first medium can be a first electrolytic solution and the second medium can be a second electrolytic solution; thus, the interface can become an interface of two immiscible electrolytic solutions (ITIES). The nanoparticle coverage of the interface, e.g., the ITIES, can be regulated to vary between approximately zero and a full or nearly a full monolayer. The nanoparticle coverage of the interface can dictate at least one optical property of the interface, rendering the interface transparent or substantially transparent, or a mirror, or providing Faraday rotation of the optical polarization of light incident normal to the interface and propagating through the interface. | 02-07-2013 |
20130024745 | MEMORY-EFFICIENT LDPC DECODING - To decode a representation of a codeword that encodes K information bits as N>K codeword bits, messages are exchanged between N bit nodes and N−K check nodes of a graph in which E edges connect the bit nodes and the check nodes. While messages are exchanged, fewer than E of the messages are stored, and/or fewer than N soft estimates of the codeword bits are stored. In some embodiments, the messages are exchanged only within sub-graphs and between the sub-graphs and one or more external check nodes. While messages are exchanged, the largest number of stored messages is the number of edges in the sub-graph with the most edges plus the number of edges that connect the sub-graphs to the external check node(s), and/or the largest number of stored soft estimates is the number of bit nodes in the sub-graph with the most bit nodes. | 01-24-2013 |
20130011029 | METHOD AND SYSTEM FOR DETECTING CONTOURS IN AN IMAGE - A method of processing an image is disclosed. The method comprises: decomposing the image into a plurality of different resolutions; and for each resolution, processing the image at the resolution to extract edge-orientation information; utilizing the edge-orientation information for identifying contours in the image; and transmitting at least the identified contours to a computer-readable medium. | 01-10-2013 |
20130004581 | CONTROLLING UPTAKE BY CELLS - Methods and devices for causing uptake of materials by cells, temporary using local chemical environment modification. The modification may be caused chemically by reducing pH. The uptake method is passive and does not require bioactivity of the cells. | 01-03-2013 |
20120330560 | METHOD AND SYSTEM FOR PREDICTING PERTUBATIONS ALTERING METABOLIC STATES - A computer implemented method for identifying genetic or environmental perturbations that induce a transformation from a source state of an individual to a target state. A flux description of reactions is calculated in the source state and a statistical test is performed on the gene expression levels of the source state versus the target state, to generate a P-value for each on the plurality of genes. Then, for each reaction the flux of the reaction in the source state is fixed and a solution for all of the fluxes that minimize an objective function is found. These perturbations are ranked by the extent by which the perturbation caused a transformation of the source state towards the target state. | 12-27-2012 |
20120312696 | METHOD OF MANUFACTURING PROTON-CONDUCTING MEMBRANES - A process for producing proton-conducting membrane, the process comprising: mixing (i) 5% to 60% by volume of an electrically nonconductive inorganic powder having a good acid absorption capacity, the powder comprising essentially nanosize particles; (ii) 5% to 50% by volume of a polymeric binder that is chemically compatible with acid, oxygen and the fuel; and (iii) 10 to 90% by volume of an acid or aqueous acid solution, wherein the mixing is conducted at various rate steps, thereby producing a proton-conducting mixture; continuously casting the proton-conducting mixture on rolled paper, non-woven matrix or the like at ambient temperature; drying the casted proton-conducting mixture at a temperature of greater than 100° C. for approximately 5 to 30 minutes, thereby forming a dry film; and laminating a plurality of the dry films together under pressure, and thereafter extracting pore-former out of pores of the dry films, thereby forming the proton-conducting membrane having an average pore size of less than 30 nanometers. | 12-13-2012 |
20120309748 | CONJUGATED PSYCHOTROPIC DRUGS AND USES THEREOF - Novel chemical conjugates of psychotropic drugs and organic acids, uses thereof in the treatment of psychotic and/or proliferative disorders and diseases and as chemosensitizing agents, and their syntheses are disclosed. The organic acids are selected to reduce side effects induced by the psychotropic drugs and/or to exert an anti-proliferative activity. | 12-06-2012 |
20120308911 | BIPOLAR PLATES AND REGENERATIVE FUEL CELL STACKS INCLUDING SAME - A bipolar plate and regenerative fuel cell stacks including the bipolar plates and membrane electrode assemblies (MEAs) alternately stacked. The bipolar plate comprises a plate main body formed of an electrically conductive material. The plate main body has a first surface and a second surface opposite the first surface. Each surface has reaction flow channels through which fluids pass. The reaction flow channels on the first surface have a plurality of ribs therebetween forming an interdigitate flow field pattern. The reaction flow channels on the second surface have a plurality of ribs therebetween forming an interdigitate flow field pattern or a flow field pattern different from an interdigitate flow field pattern, e.g., a serpentine flow field pattern. | 12-06-2012 |
20120308907 | CATALYSTS AND ELECTRODES FOR FUEL CELLS - A catalyst composition comprising at least one precious metal, wherein the catalyst composition is capable of catalyzing, in the presence of a halogen ion or a mixture of halogen ions, a charging reaction and a discharging reaction in a regenerative fuel cell. This disclosure relates to electrodes comprising those catalysts that are useful in fuel cells. The catalysts are active towards hydrogen evolution reaction (HER) and hydrogen oxidation reaction (HOR) and porous electrodes are made in a process designed to control their porosity. The catalysts and electrodes are employed in regenerative fuel cells comprising hydrogen and halogen acid or mixture of halogen acids. The catalysts are particularly useful in hydrogen/bromine reduction/oxidation reactions. The catalysts exhibit highly acceptable life and performance. | 12-06-2012 |
20120301069 | Electro-Optical Modulator Structure - The present invention discloses an ultra-compact optical modulator comprising at least one resonator on a semiconductor chip. The EO modulator modulates incoming light having a certain wavelength range and comprises a waveguide layer accommodating at least one resonator having a periodic complex refraction index distribution structure defining a periodic defect band-edge and a cladding layer; and at least one electrode; the waveguide layer, the cladding layer and the electrode forming a capacitor structure; such that when an external voltage is applied to the capacitor structure the free carrier concentration in the waveguide layer is controlled, enabling a modulation of the resonator's refractive index; wherein the periodic defect band-edge is selected to be within the wavelength range, enabling a slow-light propagation of the incoming light within the waveguide layer. | 11-29-2012 |
20120300828 | TRANSMISSION SYSTEM WITH ISI CHANNEL AND METHOD OF OPERATING THEREOF - There is provided a transmission system and method of operating thereof. The method comprises: dividing a data sequence to be transmitted into a plurality of data blocks; encoding one or more data blocks with one or more linear systematic cyclic codes thus giving rise to encoded data blocks; transmitting said encoded data blocks over an ISI transmission channel; upon receiving, applying a linear integer-forcing (IF) equalization to the received data blocks; processing the output of the IF equalization thereby detecting for each encoded data block a valid codeword with maximal likelihood of decoding; and reconstructing the data blocks using the respective detected valid codewords. | 11-29-2012 |
20120294957 | TREATMENT OF LUNG CANCER - Disclosed are methods of treating lung cancer by administering to a human in need thereof effective amounts of FTS, or various analogs thereof, or a pharmaceutically acceptable salt thereof, optionally, in combination with a chemotherapeutic agent. Chemotherapeutic agents, and combinations thereof, for use with FTS, its analogs, or its salts are also disclosed. | 11-22-2012 |
20120288877 | ELECTROCHEMICAL METHODS OF DETECTING COLON CANCER CELLS AND USE OF SAME FOR DIAGNOSING AND MONITORING TREATMENT OF THE DISEASE - A method of detecting cancer cells is disclosed. The method comprises (a) contacting the cell with a substrate for an enzyme under conditions wherein the enzyme catalyzes a reaction of the cell with the substrate, so as to generate a product capable of producing an electrical signal; and (b) measuring a level of the electrical signal, wherein a difference in a level of the electrical signal compared to a predetermined threshold is indicative of a cancer cell. The method may be adapted for diagnosis, monitoring a cancer therapy, identifying agents capable of treating cancer and individually optimizing a cancer therapy. | 11-15-2012 |
20120283956 | METHOD AND SYSTEM FOR PREDICTING SELECTIVE CANCER DRUG TARGETS - A method for creating a metabolic map of metabolic reactions by selecting metabolic reactions active in cancer cells. A core set of metabolic reactions occurring in the cancer cells is designated. For each permutation, whether inhibition of the k-th non-core reaction together with inhibition of all previously deleted non-core reactions results in inhibition of any of the core reactions or results in inhibition of the flux of biomass metabolites to biomass is determined. If inhibition of the k-th non-core reaction and inhibition of all previously deleted non-core reactions does not result in inhibition of any core reactions and does not result in inhibition of the flux of biomass metabolites to biomass, then the k-th non-core reaction is deleted from the set of non-core reactions. The number of permutations for which the k-th non-core reaction is not deleted is determined and a metabolic map is then created based on that number. | 11-08-2012 |
20120277310 | NOVEL CONJUGATES FOR TREATING NEURODEGENERATIVE DISEASES AND DISORDERS - A conjugate comprising L-DOPA covalently linked to at least one γ-aminobutyric acid (GABA) moiety, an ester and/or an addition salt thereof are disclosed, as well as uses thereof for treating a neurodegenerative disease or disorder. | 11-01-2012 |
20120270246 | PROCOLLAGEN C-PROTEINASE ENHANCER (PCPE) BIOMARKER FOR BONE FORMATION - A method of diagnosing fibrosis in a subject is provided, comprising the steps of: determining a level of PCPE in a body fluid sample obtained from said subject; and detecting an increased level of PCPE in said body fluid sample relative to a normal control level of PCPE, wherein said increased level of PCPE relative to normal control is indicative of fibrosis in said subject. Furthermore, methods for evaluating the pharmacological efficacy of a drug or a drug candidate in treatment of fibrosis in a patient and for monitoring change of fibrosis in a subject are provided. | 10-25-2012 |
20120267322 | METHOD AND SYSTEM FOR PLASMA TREATMENT OF A LIQUID - A system for plasma treatment of a liquid and corresponding uses thereof, the system comprising a chamber having a liquid input conduit and a liquid output conduit, a source of electromagnetic radiation of wavelength λ coupled to the chamber by a waveguide of appropriate width to provide only fundamental mode of the electromagnetic radiation, a focusing means positioned between the waveguide and the chamber for transmissively focusing the electromagnetic radiation incident thereon to a location within the chamber remote from walls of chamber for creating a plasma at the location, characterized in that the plasma is formed entirely within the liquid. | 10-25-2012 |
20120243551 | Efficient Processing of Compressed Communication Traffic - A method for processing communication traffic includes receiving an incoming stream of compressed data conveyed by a sequence of data packets, each containing a respective portion of the compressed data. The respective portion of the compressed data contained in the first packet is stored in a buffer, having a predefined buffer size. Upon receiving a subsequent packet, at least a part of the compressed data stored in the buffer and the respective portion of the compressed data contained in the subsequent packet are decompressed, thereby providing decompressed data. A most recent part of the decompressed data that is within the buffer size is recompressed and stored in the buffer. | 09-27-2012 |
20120225822 | PEPTIDES FOR THE TREATMENT OF OXIDATIVE STRESS RELATED DISORDERS - Isolated DJ-1 related peptides are disclosed and pharmaceutical compositions comprising same for treating oxidative stress-related disorder. | 09-06-2012 |
20120224638 | SYSTEM, METHOD AND COMPUTER PROGRAM PRODUCT FOR MOTION DETECTION - A system, computer readable medium and a method for motion detection, the method includes: receiving multiple frames; generating a set of digits for each pixel of multiple pixels of each frame of the multiple frames; wherein each set of digits represents a pixel that belongs to a patch of a frame and represents relationships between (a) first similarities between the patch and a set of patches of a next frame that are located in locations that differ from each other and differ from a location of the patch; and (b) second similarities between the patch and a set of patches of a previous frame that are located in locations that differ from each other and differ from a location of the patch; and processing the sets of digits to detect motion. | 09-06-2012 |
20120219498 | COMPOSITIONS AND METHODS FOR INDUCING ANGIOGENESIS - An isolated peptide comprising an amino acid sequence HWRR as set forth by SEQ ID NO:5, the peptide consists of 4 or 5 amino acids, is provided. Also provided are methods of treating angiogenesis-related pathologies using the peptide of the invention or pharmaceutical compositions comprising same. | 08-30-2012 |
20120213769 | METHODS OF DIAGNOSING AMYOTROPHIC LATERAL SCLEROSIS (ALS) - A method of diagnosing amyotrophic lateral sclerosis (ALS) in a subject in need thereof is provided. The method comprising determining in cells of the subject at least one alteration in a sequence or expression level of Cytoplasmic FMR Interacting Protein (CyFIP2; Accession AF160973) and/or Retinoblastoma Binding Protein 9 (RbBP9; Accession AF039564), wherein an altered sequence or expression of the sequence or expression level of the CyFIP2; Accession AF160973) or Retinoblastoma Binding Protein 9 (RbBP9; Accession AF039564) as compared to a control reference sample from a non-ALS subject, is indicative of ALS. The present teachings may be implemented in screening for novel anti-ALS medicaments and for treating ALS. | 08-23-2012 |
20120208763 | NAP ALPHA-AMINOISOBUTYRIC ACID ANALOG WITH NEUROPROTECTIVE ACTIVITY - The invention relates to compositions and methods to confer protection on neurons. Peptides derived from the NAPVSIPQ (SEQ ID NO:4) peptide and including branched amino acids, such as alpha-aminoisobutyric acid, are included. Also included are methods of preventing and treating neurodegenerative disorders and damage caused by neurotoxic substances. | 08-16-2012 |
20120207772 | ANTI-MUC1 ALPHA/BETA ANTIBODIES - The present invention provides antibodies that simultaneously bind the α- and β-subunits of an intact MUC1 protein, and methods for making and using such antibodies. | 08-16-2012 |
20120206264 | SYSTEM FOR AUTOMATIC FALL DETECTION FOR ELDERLY PEOPLE - Apparatus for detection of human falls comprises: an acceleration detector, for detecting vibration events, typically placed on a floor, a microphone, located in association with the acceleration detector for detection of corresponding sound events, and a classification unit to classify concurrent events from the microphone and the acceleration detector, thereby to determine whether a human fall is indicated. If the event appears to be a human fall, then an alarm is raised. | 08-16-2012 |
20120197364 | PHOTOELECTRICAL DEVICES FOR STIMULATING NEURONS - The present invention provides a novel photoelectrical device for efficient transmission of electrical signals to a neuron. This photoelectrical device comprises one or more charging units for coupling to and stimulating one or more neurons by charge, the charging unit comprising: a nanostructure-based electrode having a surface, which has a predetermined developed surface area for coupling to a neuron and which carries a plurality of photosensitive regions (e.g. quantum dots) interfacing with a biocompatible macromolecule for tuning the relative energy levels between the photosensitive regions and the electrode, as well as for directing the spatial polarity of charge separation the surface being thereby electrically chargeable and dischargeable in response to light excitation of the photosensitive regions, the charges stimulating the neuron when coupled to the surface. | 08-02-2012 |
20120193990 | SYSTEM AND METHOD FOR CONTROLLING A GROUP OF PHOTOVOLTAIC GENERATORS - A method for controlling a group of photovoltaic energy generators, the method includes providing, to a junction that is coupled to a component of a first photovoltaic energy generator (PEG), power generated by at least a second PEG such as to increase the power that is generated from the group of photovoltaic energy generators (PEGs); wherein the group of PEGs comprises the first PEG and the second PEG. | 08-02-2012 |
20120178785 | DERIVATIVES OF N-PHENYLANTHRANILIC ACID AND 2-BENZIMIDAZOLONE AS POTASSIUM CHANNEL AND/OR NEURON ACTIVITY MODULATORS - Compounds, compositions and methods are provided which are useful in the treatment of conditions such as central or peripheral nervous system disorders through the modulation of potassium ion flux through voltage-dependent potassium channels and/or depressing cortical and/or peripheral neuron activity are disclosed. Novel derivatives of N-phenylanthranilic acid are also disclosed. | 07-12-2012 |
20120167962 | SYSTEM AND METHOD FOR GENERATING A BEAM OF PARTICLES - A method of fabricating a film. The method comprises directing onto a substrate a pulsed supersonic beam of a molecular precursor characterized by kinetic energy of at least 1 eV per molecule, such that non-volatile species of molecules of the precursor are deposited on the substrate. | 07-05-2012 |
20120152322 | VERTICAL JUNCTION PV CELLS - A monolithic semiconductor solar cell including a semiconductor layer including a plurality of pores, wherein walls of the pores are doped, forming vertical junctions between the walls of the pores and a bulk of the semiconductor, the pores each contain a conductor which is in electrical contact with the walls of the pores, and the conductors of the pores are electrically interconnected to provide an output voltage of the solar cell. A monolithic semiconductor solar cell including a semiconductor layer including a plurality of trenches, wherein walls of the trenches are doped, forming vertical junctions between the walls of the trenches and a bulk of the semiconductor, the trenches each contain a conductor which is in electrical contact with the walls of the trenches, and the conductors of the trenches are electrically interconnected to provide an output voltage of the solar cell. Related apparatus and methods are also described. | 06-21-2012 |
20120148799 | ALIGNED NANOARRAY AND METHOD FOR FABRICATING THE SAME - An elongated nanostructure is formed on a planar surface of a substrate such that the nanostructure is oriented generally perpendicularly to the surface. The nanostructure is then felled onto the surface such that it is oriented generally parallel to the surface. | 06-14-2012 |
20120129916 | CELL-TARGETING NANOPARTICLES COMPRISING POLYNUCLEOTIDE AGENTS AND USES THEREOF - A method of generating a particle is disclosed, the particle being for delivery of a polynucleotide to a target cell. The method comprises (a) contacting the polynucleotide with a composition comprising cationic molecules, wherein the cationic molecules condense the polynucleotide by electrostatic interactions to generate a complex, wherein the cationic molecules are not comprised in a liposome; and (b) covalently binding the complex to a targeting moiety at a pH equal to or below about 4.5, thereby generating the particle for delivery of the polynucleotide agent to the target cell. Use of the particles and compositions comprising same are also disclosed. | 05-24-2012 |
20120122657 | RHENIUM NANOSTRUCTURES - The present invention provides atomic Re nanostructures selected from binary Re-metal nanotubes, binary Re-metal nanowires, binary Re-metal nanorods, Re branched nanostructures, and hollow Re nanostructures. | 05-17-2012 |
20120120551 | ELECTRODE AND METHOD OF MANUFACTURING THE SAME - A method of fabricating a device is disclosed. The method comprises coating a solid structure by nanostructures selected from the group consisting of peptides and amino acids, under conditions that at least partially prevent assembly of the nanostructures into supramolecular structures. | 05-17-2012 |
20120115202 | PHOTOCATALYTIC HYDROGEN PRODUCTION IN CYANOBACTERIA - A cyanobacterial cell comprising a PSI complex which accepts electrons from at least one respiratory cytochrome is disclosed. Methods of generating same and use of same for the production of hydrogen gas are also disclosed. | 05-10-2012 |
20120114650 | SINGLE CHAIN ANTIBODIES AGAINST BETA-AMYLOID PEPTIDE - Anti-AβP scFvs and single domain antibodies were generated, and when these antibodies were displayed on filamentous phage or as soluble protein molecules, stabilized by the maltose binding protein, they could prevent the fibrilization of Aβp 1-40 and disaggregate Aβp 1-40 fibrils generated in vitro. The anti-Aβp scFv antibodies also stained amyloid neuritic plaques on slices from transgenic mice. The anti-AβP scFv and single domain antibodies can be used for inhibiting or treating Alzheimer's disease. | 05-10-2012 |
20120114631 | STABLE ENZYMATIC PREPARATIONS AND METHODS OF USE THEREOF - The present invention relates to stable concentrated enzymatic compositions suitable for storage under ambient conditions, while maintaining their intended enzymatic activity. The invention further relate to kits comprising concentrated enzymatic compositions, methods for preparing debriding solutions from said concentrated enzymatic compositions and methods of using the diluted debriding solutions. | 05-10-2012 |
20120100158 | ANTI CEACAM1 ANTIBODIES AND METHODS OF USING SAME - A hybridoma cell which has been deposited under ATCC Accession Number PTA-9974 is disclosed. Also provided are Antibodies and methods of using same. | 04-26-2012 |
20120081245 | LINEARIZED OPTICAL DIGITAL-TO-ANALOG MODULATOR - A modulator device for converting digital data into modulation of an optical signal includes an electronic input for receiving an input data word of N bits and an electrically controllable modulator for modulating the intensity of an optical signal, the modulator including M actuating electrodes where M≧N. An electrode actuating device, most preferably a digital-to-digital converter, operates actuating electrodes so that at least one electrode is actuated as a function of values of more than one bit of the input data word. According to an alternative, or supplementary, aspect of the invention, the set of electrodes includes at least one electrode having an effective area which is not interrelated to others of the set by factors of two. In one preferred implementation, a Mach-Zehnder modulator also provides phase modulation to give QAM functionality. Another implementation employs a semiconductor laser. | 04-05-2012 |
20120065270 | POTASSIUM ION CHANNEL MODULATORS AND USES THEREOF - Compounds of formula (I) and pharmacologically acceptable salts and pro-drugs wherein: | 03-15-2012 |
20120063276 | PEPTIDE NANOSTRUCTURES AND METHODS OF GENERATING AND USING THE SAME - A tubular or spherical nanostructure composed of a plurality of peptides, wherein each of the plurality of peptides includes no more than 4 amino acids and whereas at least one of the 4 amino acids is an aromatic amino acid. | 03-15-2012 |
20120062760 | IMAGING SYSTEM AND METHOD FOR IMAGING OBJECTS WITH REDUCED IMAGE BLUR - An imaging device is presented for use in an imaging system capable of improving the image quality. The imaging device has one or more optical systems defining an effective aperture of the imaging device. The imaging device comprises a lens system having an algebraic representation matrix of a diagonalized form defining a first Condition Number, and a phase encoder utility adapted to effect a second Condition Number of an algebraic representation matrix of the imaging device, smaller than said first Condition Number of the lens system. | 03-15-2012 |
20120061471 | SYSTEM AND A METHOD FOR NANO IMPRINTING - A method for creating a highly accurate nanostructure is provided, the method includes: (i) creating a highly accurate nanostructure prototype, wherein the highly accurate nanostructure prototype, when illuminated with a predefined illumination, provides a unique optical pattern; (ii) creating at least one highly accurate nanostructure mold from the highly accurate nanostructure prototype, wherein each highly accurate nanostructure mold enables a creation of a highly accurate nanostructure that is substantially similar to the highly accurate nanostructure prototype and which, when illuminated with the predefined illumination, provides the unique optical pattern; and (iii) molding the highly accurate nanostructure using the highly accurate nanostructure mold, wherein the highly accurate nanostructure, when illuminated with the predefined illumination, provides the unique optical pattern. | 03-15-2012 |
20120060418 | CATALYTIC GASIFICATION OF ORGANIC MATTER IN SUPERCRITICAL WATER - A catalyst system including at least one metal and an oxide support, said oxide support including at least one of Al | 03-15-2012 |
20120041521 | LOW-LEVEL ENERGY LASER THERAPY - Methods and systems ( | 02-16-2012 |
20120028894 | PEPTIDES, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME AND USES THEREOF - Use of an isolated peptide comprising an amino acid sequence being no more than 25 amino acids in length, the amino acid sequence comprising at least one aspartate or a homolog thereof, the peptide having an Insulin-Degrading Enzyme (IDE) inhibitory activity, for the manufacture of a medicament identified for treating a disease selected from the group consisting of diabetes, obesity, hyperglycemia, retinal damage, renal failure, nerve damage, microvascular damage and varicella-zoster virus (VZV) infection is disclosed. | 02-02-2012 |
20120027833 | DRUG-ELUTING FILMS - Polymeric porous films, capable of eluding a bioactive agent when coming in contact with a physiological medium according to a pre-determined and controlled release profile suitable for particular type of drug and indication, and medical devices including the same are disclosed. Also disclosed are processes for producing the polymeric porous films by freeze-drying an inverted emulsion formulation in which the polymer's composition, the polymer's concentration, the polymer's initial molecular weight, the concentration and/or the type of a surfactant, the homogenization rate and/or the oil phase to aqueous phase ratio (O:A) are selected so as to impart a desired release profile of the bioactive agent from the polymeric film. | 02-02-2012 |
20120015878 | USE OF ADNF POLYPEPTIDES FOR TREATING ANXIETY AND DEPRESSION - This invention relates to the use of ADNF polypeptides in the treatment of anxiety and/or depression. The present invention also relates to drug discovery assays using the ADNF polypeptide mechanism of action and target interaction, as well as the manufacture of medicaments, methods of application and formulation therefor. Embodiments of the invention provide methods for preventing and/or treating anxiety and depression disorders in a subject by administering a NAP, an 8-amino-acid peptide derived from Activity Dependent Neurotrophic Factor (ADNF III), in an amount sufficient to improve postnatal performance. The ADNF polypeptides include ADNF I and ADNF III (also referred to as ADNP) polypeptides, analogs, subsequences, and D-amino acid versions (either wholly D-amino acid peptides or mixed D- and L-amino acid peptides), and combinations thereof which contain their respective active core sites and provide neuroprotective and anti-anxiety functions. | 01-19-2012 |
20120013911 | DEVICE AND METHOD FOR OPTICAL SENSING OF SUBSTANCES OR ENVIRONMENTAL CONDITIONS - A device for optical sensing of substances or environmental conditions in a fluid includes a number of non-overlapping adjacent sensing elements, each having a layered optical element for generating a wavelength-specific interference effect and being treated so as to respond to the presence of a predefined substance or a predefined environmental condition to cause an optically detectable change. The sensing elements are distinct from each other both in their wavelength-specific interference effect and in the corresponding optically detectable change. As a result, when the device is illuminated by a common illumination beam of multi-wavelength illumination, spectral analysis performed on the reflected or transmitted illumination enables simultaneous sensing of a plurality of substances or environmental conditions. In certain preferred implementations, the layered optical element includes at least one layer of porous silicon. | 01-19-2012 |
20120010148 | COMBINATION THERAPIES USING NAP - This invention relates to treatment of neurodegeneration, multiple sclerosis, or schizophrenia using an ADNF III polypeptide in combination with another therapeutic agent. Neurodegeneration, including neurodegeneration caused by dementia-related conditions, such as tauopathies, including Alzheimer's disease, and aging-related dementia, is treated by a combination of an ADNF III polypeptide and an acetylcholinesterase inhibitor. Multiple sclerosis is treated by a combination of an ADNF III polypeptide and glatiramer acetate. Schizophrenia is treated with a combination of an ADNF III peptide and an antipsychotic drug, selected from Aripiprazole, Clozapine, Ziprasidone, Resperidone, Quetiapine, and Olanzapine. | 01-12-2012 |
20120009673 | MESENCHYMAL STEM CELLS FOR THE TREATMENT OF CNS DISEASES - An isolated human cell is disclosed comprising at least one mesenchymal stem cell phenotype and secreting brain-derived neurotrophic factor (BDNF), wherein a basal secretion of the BDNF is at least five times greater than a basal secretion of the BDNF in a mesenchymal stem cell. Methods of generating same and uses of same are also disclosed. | 01-12-2012 |
20120004627 | APPARATUS AND METHODS FOR ENZYMATIC DEBRIDEMENT OF SKIN LESIONS - An apparatus for debridement of devitalized tissue in skin lesions, that includes a plurality of height- and angle-adjustable inlet tubes and at least one outlet tube and a member that forms an occlusive seal around a skin lesion. The plurality of inlet tubes is adapted for directing a continuous stream of enzymatic solution to the surface and into the entire volume of the wound bed of the lesion and the at least one outlet is adapted for removing the enzymatic solution, fluids draining from the lesion and tissue debris from the occluded skin lesion. | 01-05-2012 |
20120003739 | POPULATIONS OF EXPANDED AND RE-DIFFERENTIATED ADULT ISLET BETA CELLS CAPABLE OF PRODUCING INSULIN AND METHODS OF GENERATING SAME - A population of expanded adult islet beta cells is provided as well as a population of expanded and redifferentiated adult islet beta cells. Methods of generation of the populations of cells are provided. | 01-05-2012 |
20110319334 | COMPOSITIONS AND METHODS FOR PREVENTION AND TREATMENT OF NEURODEGENERATIVE DISEASES - Isolated peptides are provided, being less than 20 amino acids in length. The peptides comprising an amino acid sequence GVLYVGSKTREGV (SEQ ID NO: 12) AAATGLVKREE (SEQ ID NO: 13) or GVVAAAEKTKQG (SEQ ID NO: 14), mimetics and/or fragment thereof, the peptides being capable of inhibiting alpha synuclein aggregation. Pharmaceutical compositions comprising same are also provided as well as uses thereof. | 12-29-2011 |
20110317892 | METHOD AND SYSTEM OF CLASSIFYING MEDICAL IMAGES - A method of generating a category model for classifying medical images. The method comprises providing a plurality of medical images each categorized as one of a plurality of categorized groups, generating an index of a plurality of visual words according to a distribution of a plurality of local descriptors in each the image, modeling a category model mapping a relation between each visual word and at least one of the categorized groups according to the index, and outputting the category model for facilitating the categorization of an image based on local descriptors thereof. | 12-29-2011 |
20110313314 | METHOD AND SYSTEM FOR DETECTING NEUROPATHY - The invention provides a system and method for detecting or monitoring neuropathy in an individual. The system of the invention includes a platform having a surface in which a plurality of stimulators is embedded. Each stimulator is configured to stimulate a region in a skin area when the skin area is applied to the platform. The stimulators may deliver thermal and/or vibrational energy to the skin region. In the method of the invention, a skin area is applied to platform and one of the stimulators is activated. A minimal stimulation is determined that is sensed by the individual in a skin region in contact with a stimulator. Neuropathy in the skin region in contact with the stimulator is detected if either the determined minimal stimulation is above a predetermined threshold, or if a stimulation is not sensed before a magnitude of the stimulation reaches a predetermined maximal magnitude. The process is then repeated with other stimulators. | 12-22-2011 |
20110306571 | Methods for treating cancer - Use of a macrolide antibiotic for the manufacture of a medicament for the treatment or prevention of a cancer selected from colorectal cancer, Desmoid tumor, bladder cancer, gastric cancer, and breast cancer, the macrolide antibiotic being one or more of: tylosin, pharmaceutically acceptable salts thereof, and derivatives thereof; erythromycin, pharmaceutically acceptable salts thereof, and derivatives thereof; oleandomycin, pharmaceutically acceptable salts thereof, and derivatives thereof; and spiramycin, pharmaceutically acceptable salts thereof, and derivatives thereof. Also provided are pharmaceutical compositions and methods for the treatment or prevention of the above mentioned cancers and methods for treating or preventing, in a mammal, a cancer that expresses a mutated APC gene. | 12-15-2011 |
20110289286 | MEMORY CONTROLLER AND A METHOD FOR WRITING INFORMATION TO A K-LEVEL MEMORY UNIT - A method, a computer readable medium and a memory controller. The method for writing information to a K-level memory unit, includes: receiving a sequence of information bits; generating an information value that represents the sequence of information bits; applying a first function to the information value, to provide a first function result; selecting a first cell of the K-level memory unit as a current cell; wherein K is a positive integer that is greater than 1; writing the first function result to the first cell; and repeating the stages of: (a) reading a current cell to provide a current read result; (b) applying a second function to the current read result and to a function result that was written to the current cell, to provide a second function result; (c) selecting another cell as a current cell; and (d) writing the second function result to the current cell. | 11-24-2011 |
20110287068 | FIBRIN AND FIBRINOGEN MATRICES AND USES OF SAME - There is provided compositions-of-matter comprising fibrin or fibrinogen crosslinked with at least one reducing sugar. | 11-24-2011 |
20110286971 | TARGETED DRUG-CARRYING BACTERIOPHAGES - The present invention relates to the field of drug delivery. More specifically, the invention relates to the preparation and use of a bacteriophage conjugated through a labile/non labile linker or directly to at least 1,000 therapeutic drug molecules such that the drug molecules are conjugated to the outer surface of the bacteriophage. The bacteriophage optionally displays on its coat a ligand that endows it with specificity towards target cells. Thus, there is provided a targeted, high-capacity drug delivery system useful for the treatment of various pathological conditions. | 11-24-2011 |
20110286970 | METHOD FOR TREATING PARKINSON'S DISEASE - The present invention relates to the use of a filamentous bacteriophage, which displays an antibody that specifically binds to a pro-inflammatory cytokine, either alone or in combination with a filamentous bacteriophage that does not display a mammalian cell internalization signal, to treat Parkinson's disease. | 11-24-2011 |
20110276856 | METHOD AND DEVICE FOR MULTI PHASE ERROR-CORRECTION - Data bits to be encoded are split into a plurality of subgroups. Each subgroup is encoded separately to generate a corresponding codeword. Selected subsets are removed from the corresponding codewords, leaving behind shortened codewords, and are many-to-one transformed to condensed bits. The final codeword is a combination of the shortened codewords and the condensed bits. A representation of the final codeword is decoded by being partitioned to a selected subset and a plurality of remaining subsets. Each remaining subset is decoded separately. If one of the decodings fails, the remaining subset whose decoding failed is decoded at least in part according to the selected subset. If the encoding and decoding are systematic then the selected subsets are of parity bits. | 11-10-2011 |
20110276749 | MULTI-BIT-PER-CELL FLASH MEMORY DEVICE WITH NON-BIJECTIVE MAPPING - To store a plurality of input bits, the bits are mapped to a corresponding programmed state of one or more memory cells and the cell(s) is/are programmed to that corresponding programmed state. The mapping may be many-to-one or may be an “into” generalized Gray mapping. The cell(s) is/are read to provide a read state value that is transformed into a plurality of output bits, for example by maximum likelihood decoding or by mapping the read state value into a plurality of soft bits and then decoding the soft bits. | 11-10-2011 |
20110266517 | PEPTIDE NANOSTRUCTURES ENCAPSULATING A FOREIGN MATERIAL AND METHOD OF MANUFACTURING SAME - A composition comprising a material at least partially enclosed by a tubular, spherical or planar nanostructure composed of a plurality of peptides, wherein each of the plurality of peptides includes no more than 4 amino acids and whereas at least one of the 4 amino acids is an aromatic amino acid. | 11-03-2011 |
20110264981 | ERROR CORRECTION DECODING BY TRIAL AND ERROR - A representation of a codeword is decoded by applying a first decoder of the codeword to the representation of the codeword. If applying the first decoder fails to decode the representation of the codeword then a second decoder of the codeword is applied to the representation of the codeword. Preferably, applying the first decoder consumes less power and is faster than applying the second decoder. Data are ported by encoding the data as a codeword, exporting the codeword to a corrupting medium, importing a representation of the codeword, and applying a first decoder to the representation of the codeword. If applying the first decoder fails to decode the representation of the codeword then a second decoder of the codeword is applied to the representation of the codeword. | 10-27-2011 |
20110262447 | HUMAN SYNTHETIC SINGLE-CHAIN ANTIBODIES DIRECTED AGAINST THE COMMON EPITOPE OF MUTANT P53 AND THEIR USES - Isolated polypeptides, isolated polynucleotides or expression vectors encoding same, viral display vehicles which can be specifically bind an exposed epitope shared by mutant, but not wild type, p53 protein are provided. Also provided are methods of inducing apoptosis and treating cancer as well as diagnosing a p53-related cancer using the isolated polypeptides uncovered by the present invention. | 10-27-2011 |
20110258370 | MULTIPLE PROGRAMMING OF FLASH MEMORY WITHOUT ERASE - To store, successively, in a plurality of memory cells, first and second pluralities of input bits that are equal in number, a first transformation transforms the first input bits into a first plurality of transformed bits. A first portion of the cells is programmed to store the first transformed bits according to a mapping of bit sequences to cell levels, but, if the first transformation has a variable output length, only if there are few enough first transformed bits to fit in the first cell portion. Then, without erasing a second cell portion that includes the first portion, if respective levels of the cells of the second portion, that represent a second plurality of transformed bits obtained by a second transformation of the second input bits, according to the mapping, are accessible from the current cell levels, the second portion is so programmed to store the second transformed bits. | 10-20-2011 |
20110245250 | POTASSIUM ION CHANNEL MODULATORS & USES THEREOF - Compounds of formula (I) and pharmacologically acceptable salts and pro-drugs thereof wherein: | 10-06-2011 |
20110242645 | SYSTEM AND METHOD FOR CONTROLLING OPTICAL OUTPUT OF A FREQUENCY CONVERSION DEVICE - A system and method for improving conversion efficiency of a difference frequency generator (DFG) and/or for outputting a desired shape of the output signal, where the method includes providing a pump source, modifying the pump pulse temporal shape for optimal DFG conversion efficiency, and providing the modified pump pulse to the DFG. The pump source may be, for example, a MOPA laser or a diode or any other suitable source. In one embodiment, the pump pulse shape is modified such that an initial gain within the DFG is high, followed by a lower level signal for efficient conversion within the DFG. An example of such a shape is a double square pulse. Other configurations are possible as well such as a single rectangular pulse shape. | 10-06-2011 |
20110224184 | NAPHTHOQUINONE DERIVATIVES USEFUL FOR PREVENTION OF AMYLOID DEPOSITS AND TREATMENT OF DISEASES INVOLVING AMYLOIDOGENESIS - The present invention provides pharmaceutical compositions comprising substituted 1,4 naphthoquinones that are effective in preventing oligomerization of beta amyloid and subsequent pathologies associated with amyloid fibrils. These compositions are useful for the treatment of disease involving amyloidogenesis including neurodegenerative diseases such as Alzheimer's Disease or senile dementia. Particularly effective compositions comprise 1,4 naphthoquinones substituted with an amino acid residue selected from a heterocyclic or aromatic amino acid. | 09-15-2011 |
20110222763 | DEVICES AND METHODS OF READING MONOCHROMATIC PATTERNS - A method of extracting data from an identifiable monochromatic pattern. The method comprises separating a polychromatic optical signal, received from an object having identifiable monochromatic pattern, into a plurality of wavelength components, separately capturing each of the wavelength components, reconstructing a plurality of images each from a different wavelength component, detecting the identifiable monochromatic pattern in one or more of the images, and extracting data associated with or encoded by the detected identifiable monochromatic pattern. The images have different depths of field. | 09-15-2011 |
20110215716 | NANOMATRIX SEPARATION OF CHROMOPHORES AND USES THEREOF IN LUMINESCENT DEVICES - A system and process for controlling electronic interactions between two or more interactable materials. | 09-08-2011 |
20110212896 | PEPTIDES FOR THE TREATMENT OF OXIDATIVE STRESS RELATED DISORDERS - Isolated DJ-1 related peptides are disclosed and pharmaceutical compositions comprising same for treating oxidative stress-related disorder. | 09-01-2011 |
20110210309 | TUBULAR NANOSTRUCTURES, PROCESSES OF PREPARING SAME AND DEVICES MADE THEREFROM - Novel methods of producing single-walled and multi-walled, single-crystalline, tubular nanostructures, made of an inorganic substance (e.g., silicon), and single-walled and multi-walled, single-crystalline, tubular nanostructures produced thereby, are disclosed. Also disclosed are devices into which the nanostructures are integrated. The methods described herein are used to reproducibly and controllably producing single-crystalline nanostructures with well-defined shape, diameter and/or interwall distance, chemical composition and morphology. | 09-01-2011 |
20110200692 | USE OF A CINNAMON BARK EXTRACT FOR TREATING AMYLOID-ASSOCIATED DISEASES - The present application disclosed the use of a cinnamon extract in the treatment of amyloid-associated diseases and disorders, such as Alzheimer's disease. | 08-18-2011 |
20110197428 | OPTICAL MASK FOR ALL-OPTICAL EXTENDED DEPTH-OF-FIELD FOR IMAGING SYSTEMS UNDER INCOHERENT ILLUMINATION - A method of optical element manufacturing, the method may include selecting a range of a misfocus parameter ψ; and designing the optical element to comprise multiple regions, wherein the optical transfer function (OTF) of the optical element allows, for the range of the misfocus parameter ψ, transmission of images with a contrast of at least 10% for all normalized spatial frequencies up to 50% of a theoretical maximum that is attainable with a full aperture in an in-focus condition. | 08-18-2011 |